glp 1 and parkinson's Incretin insulin signaling as novel therapeutic targets for Alzheimer's and disease The critical role of GLP-1

Gallagher, to introduce yourself please

Though findings have been promising, there is a need for gold-standard randomized controlled trials to inform clinical decision making and practice

doi: 10.1038/nchembio.209 78 FinanBYangBOttawayNSmileyDLMaTClemmensenCet al

I have no affiliation with the company

Common Mild Side Effects These typically appear during the first few weeks of use: Increased hunger Especially with Ipamorelin due to ghrelin receptor stimulation Mild water retention Often resolves after the body adjusts Tingling or numbness Usually in fingers or hands (transient) Lightheadedness More common with higher doses or low-carb diets Most of these effects are dose-dependent and subside within a week or two